T. J. Scallen

Membrane Cholesterol Dynamics: Cholesterol Domains and Kinetic Pools

J. Knittel, W. G. Wood, I. Hapala, 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Role of mevalonic acid in the regulation of natural killer cell cytotoxicity

A. Bankhurst, J. Watson, T. J. Scallen, 1989, Journal of cellular physiology.

Regulation of membrane cholesterol domains by sterol carrier protein-2.

P. Butko, I. Hapala, F. Schroeder, 1994, Biochemistry.

Cholesterol enrichment enhances expression of sterol-carrier protein-2: implications for its function in intracellular cholesterol trafficking.

D. Hajjar, S. Kesav, R. Kraemer, 1995, Journal of lipid research.

Design and biological evaluation of a series of thiophene-based 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

G. Coppola, T. J. Scallen, R. Engstrom, 1997 .

Design and synthesis of 4-oxoquinolin-2-yl-6-heptenoic acid derivatives as HMG-CoA reductase inhibitors

G. Coppola, T. J. Scallen, A. DelPrete, 1989 .

Participation of sterol carrier protein-2 in cholesterol metabolism.

S. Kesav, T. J. Scallen, J. McLaughlin, 1992, Biochemical Society transactions.

Intermembrane cholesterol transfer: Role of sterol carrier proteins and phosphatidylserine

P. Butko, I. Hapala, F. Schroeder, 1990, Lipids.